Early trial tests new shot for common liver disease
Disease control
Recruiting now
This early-stage study aims to find out if a new injectable medicine called TGM-312-SC01 is safe and how it behaves in the body. It will first test single doses in healthy adults, then test multiple doses in adults diagnosed with MASH, a serious form of fatty liver disease. The m…
Phase: PHASE1, PHASE2 • Sponsor: Tangram Therapeutics Plc • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC